AstraZeneca’s drug Tagrisso approved in China in early lung cancer
British drugmaker AstraZeneca on Wednesday said its drug Tagrisso has been approved in China for treatment of some patients with early stage lung cancer.China's National Medical Products Administration (NMPA) approved the drug as an…